A Cleveland developer that started building at the Pittsburgh Technology Center about 15 years ago is showing no signs of stopping.

The Ferchill Group is getting ready to start its third building at the South Oakland complex — a five-story, 140,302-square-foot facility tailored for biotechnology tenants.

URA board members are expected to vote today on whether to sell a 1.2-acre parcel at the riverfront site to Ferchill for $564,000 to make way for the development.

According to the URA agenda, Bridgeside Point III will be designed specifically for wet lab and other research-oriented uses.

Advertise with us

As now proposed, the four top floors would feature 80 percent lab space and 20 percent office space. The first floor would contain a core research facility to be shared by all tenants.

The proposed $70 million building follows the development of Bridgeside Point II, a five-story, 160,000-square-foot lab research building that cost more than $60 million to erect, and Bridgeside Point I, a $21.5 million, 153,000-square-foot building that opened in 2002.

It is the latest project is what is a mini building boom at the South Oakland site. A Hotel Indigo also is under development there, along with a proposed 352-unit apartment complex.

Energy plant proposal

Also today, the URA board will vote on whether to authorize exclusive negotiations with NRG DG Development LLC for the sale or lease of vacant land at Our Way and Colwell Street in Uptown for the possible development of an energy plant to serve the area.

Advertise with us

If the measure is approved, NRG plans to begin an engineering feasibility study as an initial step toward construction of the plant, which could serve UPMC Mercy Hospital, the former Civic Arena site and Chatham Center.

The plant could be incorporated into a parking garage or built to accommodate a garage in the future, according to the URA agenda.

Mark Belko: mbelko@post-gazette.com or 412-263-1262.